The mean SAA level is more than 5-fold higher in NSCLC and SCLC patients than controls (p <10−36 and p < 10−6) and the mean CRP level is increased in patients by more than 7-fold (p < 10−37 and p < 10−5). This evidence concerns the gene CRP and non-small cell lung carcinoma.